
QIAGEN N.V. QGEN
Annual report 2025
added 04-18-2026
QIAGEN N.V. Current Ratio 2011-2026 | QGEN
Annual Current Ratio QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.88 | 1.94 | 1.85 | 2.02 | 3.36 | 3.58 | 2.66 | 2.73 | 3.72 | 1.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.72 | 1.55 | 2.53 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 202.97 | -0.04 % | $ 22.5 B | ||
|
Celcuity
CELC
|
1.27 | $ 89.49 | 1.06 % | $ 4.18 B | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
6.01 | $ 4.1 | -4.43 % | $ 5.45 M | ||
|
Fulgent Genetics
FLGT
|
11.4 | $ 18.7 | 0.08 % | $ 576 M | ||
|
Castle Biosciences
CSTL
|
5.37 | $ 20.51 | -0.92 % | $ 595 M | ||
|
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
0.338 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
2.95 | $ 1.6 | -3.03 % | $ 7.08 M | ||
|
Illumina
ILMN
|
6.69 | $ 161.5 | 0.33 % | $ 25 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
0.953 | $ 129.51 | -1.61 % | $ 16.2 B | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 22.75 | -0.96 % | $ 1.21 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 | $ 146.68 | 0.34 % | $ 11.5 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
0.994 | $ 1 146.92 | 1.58 % | $ 23.6 B | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.42 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
1.12 | $ 18.78 | -0.05 % | $ 420 M | ||
|
Natera
NTRA
|
3.5 | $ 211.42 | -0.31 % | $ 28.9 B | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 104.16 | -0.34 % | $ 7.03 B | ||
|
Pacific Biosciences of California
PACB
|
1.01 | $ 1.33 | 1.15 % | $ 399 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 190.12 | 1.39 % | $ 9.42 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 470.72 | 0.72 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
2.6 | $ 11.12 | -0.31 % | $ 1.42 B | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.26 | -1.59 % | $ 394 M | ||
|
Personalis
PSNL
|
4.58 | $ 9.7 | 1.15 % | $ 866 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.69 | $ 27.04 | 2.19 % | $ 25.6 B | ||
|
Twist Bioscience Corporation
TWST
|
3.8 | $ 79.05 | 3.78 % | $ 4.73 B | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 7.34 | 2.16 % | $ 306 M | ||
|
Soleno Therapeutics
SLNO
|
4.96 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
3.23 | $ 2.05 | - | $ 4.71 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 265.64 | -0.2 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
1.92 | $ 473.34 | 0.95 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
0.746 | $ 0.65 | - | $ 233 M | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.51 | $ 9.24 | 1.54 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M |